Penny Lovat

Professor Penny Lovat has over 30 years experience in translational medical research and is internationally renowned for her work in the melanoma field in which she has contributed to the characterization of the molecular events leading to deregulated cellular signalling in both cutaneous and uveal melanoma, with particular emphasis on apoptosis and autophagy and the development of novel biomarkers, therapeutic targets and therapeutic approaches to both prevent and treat metastatic disease. Penny has published over 70 manuscripts (current h index: 30) with >8,000 citations, including several publications in leading dermatology and cancer journals as well as being the principal investigator of numerous research studies funded both nationally and internationally. Penny has also served as a committee member of The British Society of Investigative Dermatology, and as a member of several grant advisory boards including for The British Skin Foundation.